PCN6 PRESERVED ANTITUMOR ACTIVITY AND REDUCED CARDIOTOXICITY OF FIRST-LINE PEGYLATED LIPOSOMAL DOXORUBICIN COMPARED WITH CONVENTIONAL DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST CANCER
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)71903-9
https://www.valueinhealthjournal.com/article/S1098-3015(11)71903-9/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
58
First Page :
A251
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71903-9&doi=10.1016/S1098-3015(11)71903-9